August 2026—Werfen and Oxford Nanopore Technologies have entered a strategic collaboration to validate Werfen’s transplant assay portfolio, including solutions for human leukocyte antigen typing and pretransplant matching, for use on Oxford Nanopore sequencing platforms. The collaboration streamlines and provides validated sample-to-answer workflows, with the aim of enabling laboratories to implement high-quality testing with reduced complexity and faster results.
Werfen, 800-955-9525
Oxford Nanopore Technologies, 833-560-2266